Metronidazol Orifarm

Metronidazole, the active ingredient in Metronidazol Orifarm, is a nitroimidazole antibiotic presented as an oral tablet for systemic use. It treats anaerobic bacterial infections and certain protozoal diseases in adults and children as prescribed.

GNH USA supplies Metronidazol Orifarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metronidazol Orifarm is a nitroimidazole antibiotic used to manage infections caused by anaerobic bacteria and susceptible protozoa. - Bacterial vaginosis: restores normal vaginal flora by eliminating anaerobic overgrowth. - Trichomoniasis: eradicates Trichomonas vaginalis, relieving symptoms and preventing transmission. - Anaerobic bacterial infections (intra‑abdominal, skin, bone): provides bactericidal activity against mixed anaerobes. - Amoebic dysentery (Entamoeba histolytica): clears intestinal trophozoites and cysts. - Clostridioides difficile infection (adjunct): reduces toxin‑producing bacterial load when used with standard therapy.

Metronidazol Orifarm may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: transient metallic sensation in the mouth. - Headache: occasional dull or throbbing pain. - Diarrhea: loose stools that may be self‑limiting.

Serious or Rare Side Effects: - Seizures: rare neurologic events requiring immediate care. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reactions: rash, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: serious skin and mucous membrane disorder. - Hepatotoxicity: elevated liver enzymes or jaundice. - Blood dyscrasias: neutropenia or agranulocytosis.

Before prescribing Metronidazol Orifarm, clinicians should consider several safety aspects. - Liver function assessment: monitor hepatic enzymes in patients with liver disease. - Alcohol avoidance: advise patients to abstain from alcohol to prevent disulfiram‑like reactions. - Pregnancy caution: use only if benefits outweigh potential risks, as safety data are limited. - Renal impairment: adjust dosing in severe kidney dysfunction. - Neurologic disorders: use cautiously in patients with seizure disorders or CNS disease. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Metronidazol Orifarm can interact with several medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Alcohol: may cause severe flushing, tachycardia, and hypotension. - Warfarin: potentiates anticoagulant effect, increasing bleeding risk. - Lithium: may raise lithium serum concentrations, leading to toxicity.

Moderate Interactions (Monitor Closely): - Phenytoin: may reduce phenytoin levels, requiring dose adjustment. - Cimetidine: can increase metronidazole plasma concentrations. - Carbamazepine: may lower metronidazole levels, potentially reducing effectiveness.